Christina Mateus

5.1k total citations
11 papers, 524 citations indexed

About

Christina Mateus is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Christina Mateus has authored 11 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Dermatology. Recurrent topics in Christina Mateus's work include Melanoma and MAPK Pathways (5 papers), Chemotherapy-related skin toxicity (4 papers) and CAR-T cell therapy research (3 papers). Christina Mateus is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Chemotherapy-related skin toxicity (4 papers) and CAR-T cell therapy research (3 papers). Christina Mateus collaborates with scholars based in France, Canada and Italy. Christina Mateus's co-authors include Caroline Robert, Alan Spatz, Bernard Escudier, Janine Wechsler, Émilie Lanoy, Émilie Routier, Michèle Verschoore, Cécile Charles, Stéphan Vagner and Lise Boussemart and has published in prestigious journals such as Nature, The Lancet Oncology and Journal of the American Academy of Dermatology.

In The Last Decade

Christina Mateus

10 papers receiving 514 citations

Peers

Christina Mateus
Rachael Anforth Australia
Philip Eliades United States
P. Buhl-Jensen United Kingdom
Matko Kalac United States
Maryann Mikhail United States
Shanta Chawla United States
Jian‐Zhong Qin United States
Rachael Anforth Australia
Christina Mateus
Citations per year, relative to Christina Mateus Christina Mateus (= 1×) peers Rachael Anforth

Countries citing papers authored by Christina Mateus

Since Specialization
Citations

This map shows the geographic impact of Christina Mateus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Mateus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Mateus more than expected).

Fields of papers citing papers by Christina Mateus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Mateus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Mateus. The network helps show where Christina Mateus may publish in the future.

Co-authorship network of co-authors of Christina Mateus

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Mateus. A scholar is included among the top collaborators of Christina Mateus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Mateus. Christina Mateus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mateus, Christina. (2018). 53 Cutaneous Squamous Cell Carcinoma. PubMed. 64(1). 45–52. 5 indexed citations
2.
Réguerre, Yves, Daniel Orbach, Caroline Robert, et al.. (2016). Cutaneous malignant melanoma in children and adolescents treated in pediatric oncology units. Pediatric Blood & Cancer. 63(11). 1922–1927. 18 indexed citations
3.
Robert, Caroline, V. Sibaud, Christina Mateus, et al.. (2015). Nail toxicities induced by systemic anticancer treatments. The Lancet Oncology. 16(4). e181–e189. 98 indexed citations
4.
Robert, Caroline & Christina Mateus. (2014). Mélanome — Thérapeutique par les médications : anticorps anti-CTLA-4 et anti-PD1. Bulletin de l Académie Nationale de Médecine. 198(2). 297–308. 3 indexed citations
5.
Routier, Émilie, Caroline Robert, & Christina Mateus. (2014). L’immunothérapie dans le mélanome. Bulletin du Cancer. 101(2). S13–S24. 5 indexed citations
6.
Boussemart, Lise, Hélène Malka-Mahieu, Isabelle Girault, et al.. (2014). eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature. 513(7516). 105–109. 261 indexed citations
7.
Robert, Caroline, Andréa Cavalcanti, Benjamin Sarfati, et al.. (2014). [Management of patients with melanoma].. PubMed. 64(1). 75–80.
8.
Robert, Caroline, Christina Mateus, Émilie Routier, et al.. (2013). Metastatic melanoma: New paradigms of treatment and new toxicities. European Journal of Cancer Supplements. 11(2). 278–280. 1 indexed citations
9.
Charles, Cécile, Serge Sultan, Catherine Bungener, et al.. (2013). Impact des toxicités cutanées associées aux thérapies ciblées sur la qualité de vie. Résultats d’une étude pilote longitudinale. Bulletin du Cancer. 100(3). 213–222. 13 indexed citations
10.
Beller, Christine Le, et al.. (2012). Cutaneous side effects associated with sunitinib: an analysis of 8 cases. International Journal of Clinical Pharmacy. 34(2). 286–289. 11 indexed citations
11.
Robert, Caroline, Christina Mateus, Alan Spatz, Janine Wechsler, & Bernard Escudier. (2008). Dermatologic symptoms associated with the multikinase inhibitor sorafenib. Journal of the American Academy of Dermatology. 60(2). 299–305. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026